A61K 9/10
Dispersions
Official title: Dispersions; Emulsions
A61K9/10 (Dispersions) appears on 12,582 US grants and 21,381 published applications in this corpus.
Search patents in A61K- Granted patents
- 12,582
- Published applications
- 21,381
- Assignees
- 7,128
- Inventors
- 32,613
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 8 | 0 |
| 1978 | 11 | 0 |
| 1979 | 8 | 0 |
| 1980 | 21 | 0 |
| 1981 | 14 | 0 |
| 1982 | 22 | 0 |
| 1983 | 16 | 0 |
| 1984 | 20 | 0 |
| 1985 | 31 | 0 |
| 1986 | 31 | 0 |
| 1987 | 33 | 0 |
| 1988 | 52 | 0 |
| 1989 | 72 | 0 |
| 1990 | 93 | 0 |
| 1991 | 105 | 0 |
| 1992 | 102 | 0 |
| 1993 | 101 | 0 |
| 1994 | 94 | 0 |
| 1995 | 102 | 0 |
| 1996 | 112 | 0 |
| 1997 | 204 | 0 |
| 1998 | 257 | 0 |
| 1999 | 251 | 0 |
| 2000 | 206 | 0 |
| 2001 | 216 | 93 |
| 2002 | 219 | 312 |
| 2003 | 197 | 438 |
| 2004 | 155 | 474 |
| 2005 | 107 | 470 |
| 2006 | 203 | 449 |
| 2007 | 104 | 453 |
| 2008 | 117 | 504 |
| 2009 | 107 | 515 |
| 2010 | 183 | 627 |
| 2011 | 196 | 624 |
| 2012 | 288 | 696 |
| 2013 | 354 | 810 |
| 2014 | 499 | 948 |
| 2015 | 518 | 920 |
| 2016 | 586 | 1042 |
| 2017 | 671 | 1056 |
| 2018 | 647 | 1073 |
| 2019 | 646 | 1241 |
| 2020 | 735 | 1251 |
| 2021 | 691 | 1379 |
| 2022 | 706 | 1349 |
| 2023 | 642 | 1381 |
| 2024 | 663 | 1289 |
| 2025 | 683 | 1141 |
| 2026 | 478 | 846 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Liposomal enhanced intra-peritoneal chemotherapy6 Oct 2026US 12,751,919 B2
- Methods of preparation of pan TLR antagonistic liposomal-LNP formulations and uses thereof6 Oct 2026US 12,751,920 B2Celestial Therapeutics, Inc.
- Medication that protects the intestinal microbiota and their preparation methods and applications6 Oct 2026US 12,751,921 B2University of Science and Technology of China
- Assisted loading of hydrophobic molecules into liposomes6 Oct 2026US 12,751,922 B2University of Connecticut
- Amorphous nilotinib microparticles and uses thereof6 Oct 2026US 12,751,950 B2Flex Pharma, LLC
- Suspension containing heterocyclidene acetamide derivative8 Oct 2026US 2026/0306401 A1Mochida Pharmaceutical Co., Ltd.
- Aqueous formulations comprising fullerene, structured water, dissolved hydrogen gas, minerals and additives8 Oct 2026US 2026/0306402 A1Best Planet Science LLC
- Modified liposome for drug delivery, use of liposome for drug delivery, especially with anti-cancer activity, and ways to load liposome with drugs, especially with anti-cancer activity8 Oct 2026US 2026/0306403 A1Bs Biotechna Spolka Akcyjna
- Liposome compositions and medical uses thereof8 Oct 2026US 2026/0306404 A1
- Leveraging lipid-protein interactions to engineer spatial organization in cell-free systems8 Oct 2026US 2026/0306405 A1
Most cited
By later US patents
- Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides1,595US 4,522,811 ASyntex (U.S.A.) Inc. · 1985
- Drug administration method1,497US 7,427,607 B2Next21 K.K. · 2008
- Delivery of exogenous DNA sequences in a mammal1,218US 5,580,859 AVical Incorporated · 1996
- Method of encapsulating biologically active materials in lipid vesicles1,201US 4,235,871 A1980
- Liposomes with enhanced circulation time1,198US 5,013,556 ALiposome Technology, Inc. · 1991